Literature DB >> 6324572

Cerebral gigantism associated with Wilms' tumor.

V Maldonado, P S Gaynon, A K Poznanski.   

Abstract

Two children had cerebral gigantism in unique association with Wilms' tumor. An increased incidence of neoplasms has been reported in cerebral gigantism, as well as in Beckwith-Wiedemann syndrome. We report similarities and differences between these disorders.

Entities:  

Mesh：

Year:  1984        PMID： 6324572     DOI： 10.1001/archpedi.1984.02140430062016

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN： 0002-922X


  6 in total

1.  Sotos syndrome.

Authors:  T R Cole; H E Hughes
Journal:  J Med Genet       Date:  1990-09       Impact factor: 6.318

2.  Neuroblastoma in a patient with Sotos' syndrome.

Authors:  M A Nance; J P Neglia; D Talwar; S A Berry
Journal:  J Med Genet       Date:  1990-02       Impact factor: 6.318

3.  Cerebral gigantism (Sotos syndrome). Compiled data of 22 cases. Analysis of clinical features, growth and plasma somatomedin.

Authors:  J M Wit; F A Beemer; P G Barth; J W Oorthuys; P F Dijkstra; J L Van den Brande; N J Leschot
Journal:  Eur J Pediatr       Date:  1985-07       Impact factor: 3.183

4.  Facioscapulohumeral muscular dystrophy: aspects of genetic counselling, acceptance of preclinical diagnosis, and fitness.

Authors:  S Eggers; M R Passos-Bueno; M Zatz
Journal:  J Med Genet       Date:  1993-07       Impact factor: 6.318

5.  Small cell lung carcinoma in a patient with Sotos syndrome: are genes at 3p21 involved in both conditions?

Authors:  T R Cole; H E Hughes; M J Jeffreys; G T Williams; M M Arnold
Journal:  J Med Genet       Date:  1992-05       Impact factor: 6.318

6.  Expanding the Clinical Spectrum of Sotos Syndrome in a Patient with the New "c.[5867T>A]+[=]"; "p.[Leu1956Gln]+[=]" NSD1 Missense Mutation and Complex Skin Hamartoma.

Authors:  Annalisa Mencarelli; Paolo Prontera; Amedea Mencarelli; Daniela Rogaia; Gabriela Stangoni; Massimiliano Cecconi; Susanna Esposito
Journal:  Int J Mol Sci       Date:  2018-10-16       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.